HCWB HCW Biologics Inc. - Common Stock
$2.26
价格 · 八月 19, 2026
截至...的财报数据 八月 14, 2026
52周区间
$0–$7
28% of range
分析师评级
BUY
7 analysts
目标价
$30
+1227% upside
P/E (TTM)
-0.1
ROE
-586.8%
净利润率
-14677.1%
HCWB 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.26
市值
—
P/E (TTM)
-0.1
每股收益 (TTM)
$-10.63
营收 (TTM)
$54.2K
股息收益率
—
ROE
-586.8%
负债/权益
2.5
52周区间
$0 – $7
HCWB 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$54.2K
2020-12-31
→
2025-12-31
EPS
$-10.63
2021-12-31
→
2025-12-31
自由现金流
$-13M
2021-12-31
→
2025-12-31
利润率
-14677.1%
2022-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
HCWB
同行中位数
P/E (TTM)
-0.1
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
HCWB
同行中位数
Gross Margin (毛利率)
20.0%
66.5%
Operating Margin (营业利润率)
-24270.7%
—
Net Profit Margin (净利润率)
-14677.1%
-313.2%
ROA
-29.1%
-105.1%
ROE
-586.8%
-142.1%
ROIC
-137.5%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
HCWB
同行中位数
Debt / Equity (负债/股东权益比率)
2.5
0.0
Current Ratio (流动比率)
0.1
1.6
Quick Ratio (速动比率)
0.1
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
HCWB
同行中位数
Revenue YoY (营收同比增长)
-97.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-79.9%
—
Revenue CAGR 5Y (营收5年复合年增长率)
-57.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
HCWB
同行中位数
HCWB 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-08-16
最低
$30.00
最高
$30.00
中位数目标
$30.00
+1227.4%
平均目标
$30.00
+1227.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-6.2%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $2.22 | $-2.69 | 4.9% |
| 2025年12月31日 | $-18.36 | $-5.14 | -13.2% |
| 2025年9月30日 | $-12.12 | $-14.08 | 2.0% |
| 2025年6月30日 | $-6.48 | $11.02 | -17.5% |
| 2024年12月31日 | $-3.20 | $3.67 | -6.9% |
| 2023年12月31日 | $-12.00 | $-5.71 | -6.3% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| TCRT | — | -1.5 | -50.0% | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| MBRX | — | — | — | — | — | — |
| REVB | — | — | — | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | — |
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $54.2K | $3M | $3M | $7M | $0 | $4M | |
| Cost of Revenue | $43.4K | $2M | $2M | $4M | $0 | · | |
| Gross Profit | $10.8K | $959.4K | $560.4K | $3M | $0 | · | |
| R&D Expense | $5M | $6M | $8M | $9M | $8M | $7M | |
| SG&A Expense | $8M | $7M | $7M | $8M | $5M | $3M | |
| Operating Expenses | $13M | $30M | $26M | $18M | $13M | $10M | |
| Operating Income | $-13M | $-29M | $-26M | $-15M | $-13M | $-6M | |
| Interest Expense | $845.1K | $654.3K | $283.0K | $126.7K | $0 | · | |
| Other Non-op | $0 | $-1M | · | · | · | · | |
| Pretax Income | $-8M | $-30M | $-25M | $-15M | $-13M | $-6M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-30M | $-25M | $-15M | $-13M | $-6M | |
| EPS (Basic) | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 | · | |
| EPS (Diluted) | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 | · | |
| Shares (Basic) | 2,097,701 | 969,825 | 35,929,446 | 35,822,249 | 18,770,935 | · | |
| Shares (Diluted) | 2,097,701 | 969,825 | 35,929,446 | 35,822,249 | 18,770,935 | · | |
| EBITDA | $-12M | $-28M | $-25M | $-14M | $-13M | · |
资产负债表 25
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $4M | $22M | $12M | $8M | |
| Short-term Investments | $0 | $0 | $0 | $10M | $25M | · | |
| Receivables | $32.2K | $582.2K | $2M | $417.7K | $133.0K | $2M | |
| Prepaid Expense | $222.2K | $328.2K | $1M | $1M | $2M | $538.3K | |
| Other Current Assets | $77.6K | $113.5K | $230.9K | $196.0K | $1M | $654.5K | |
| Current Assets | $2M | $6M | $6M | $34M | $40M | $12M | |
| PP&E (Net) | $21M | $23M | $20M | $11M | $1M | $2M | |
| PP&E (Gross) | $25M | $27M | $23M | $13M | $3M | $3M | |
| Accum. Depreciation | $4M | $4M | $3M | $2M | $2M | $1M | |
| Other Non-current Assets | $28.5K | $28.5K | $56.5K | $333.9K | $393.3K | $34.2K | |
| Total Assets | $25M | $30M | $29M | $47M | $54M | $15M | |
| Accounts Payable | $13M | $22M | $6M | $1M | $223.7K | $155.3K | |
| Short-term Debt | $7M | $6M | $0 | · | · | · | |
| Current Liabilities | $21M | $30M | $9M | $3M | $2M | $1M | |
| Capital Leases | · | · | · | $14.3K | · | · | |
| Deferred Tax | $24.9K | $40.9K | $146.9K | $0 | · | · | |
| Other Non-current Liabilities | $692.5K | · | · | · | · | · | |
| Total Liabilities | $22M | $37M | $15M | $9M | $2M | · | |
| Long-term Debt | $0 | $7M | $6M | $6M | $0 | · | |
| Total Debt | $7M | $6M | $119.4K | $38M | · | · | |
| Common Stock | $55 | $111 | $3.6K | $3.6K | $3.6K | · | |
| Paid-in Capital | $111M | $94M | $84M | $83M | $82M | $0 | |
| Retained Earnings | $-109M | $-101M | $-71M | $-46M | $-31M | $-17M | |
| Stockholders' Equity | $3M | $-7M | $13M | $37M | $51M | $-17M | |
| Liabilities + Equity | $25M | $30M | $29M | $47M | $54M | $15M |
现金流 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $717.9K | $543.6K | $572.9K | |
| Stock-based Comp | $768.6K | $1M | $1M | $1M | $361.0K | $21.9K | |
| Other Non-cash | $-7M | $14M | $341.2K | $3M | $982.2K | · | |
| Operating Cash Flow | $-13M | $-14M | $-23M | $-10M | $-11M | $-10M | |
| CapEx | $0 | $261.6K | $6M | $10M | $47.3K | $186.7K | |
| Investing Cash Flow | $0 | $-261.6K | $4M | $15M | $-35M | $-186.7K | |
| Debt Issued | · | · | · | · | $0 | $563.6K | |
| Net Debt Issued | · | · | · | · | $0 | · | |
| Stock Issued | $5M | $6M | $23.7K | $15.8K | $29.5K | $9.9K | |
| Net Stock Activity | $5M | $6M | $23.7K | $15.8K | $29.5K | · | |
| Financing Cash Flow | $11M | $16M | $-14.5K | $6M | $49M | $12M | |
| Net Change in Cash | $-3M | $1M | $-19M | $11M | $3M | $1M | |
| Free Cash Flow | $-13M | $-14M | $-29M | $-21M | $-11M | · | |
| Levered FCF | $-14M | $-15M | · | $-21M | · | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 20.0% | 37.4% | 19.7% | 38.5% | · | · | |
| Operating Margin | -24270.7% | -1148.5% | -905.0% | -224.3% | · | · | |
| Net Margin | -14677.1% | -1169.7% | -879.5% | -221.7% | · | · | |
| Pretax Margin | -14677.1% | -1169.7% | -879.5% | -221.7% | · | · | |
| EBITDA Margin | -22349.8% | -1102.4% | -865.0% | -213.6% | · | · | |
| ROA | -29.1% | -102.2% | · | -29.7% | -37.3% | · | |
| ROE | -586.8% | 358.7% | · | -37.3% | -24.4% | · | |
| ROIC | -137.5% | 6472.1% | · | -19.9% | -26.1% | · |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.2 | · | 11.5 | 17.4 | · | |
| Quick Ratio | 0.1 | 0.2 | · | 11.0 | 15.9 | · | |
| Debt / Equity | 2.5 | -0.9 | · | 1.0 | · | · | |
| Interest Coverage | -15.6 | -46.7 | -90.9 | -119.0 | · | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.1 | · | · | |
| Receivables Turnover | 0.2 | 2.4 | · | 24.4 | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -97.9% | -9.7% | -57.7% | · | · | · | |
| Revenue CAGR 3Y | -79.9% | · | -11.5% | · | · | · | |
| Revenue CAGR 5Y | -57.9% | · | · | · | · | · |
估值 (TTM) 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $54.2K | $3M | $3M | $7M | $0 | · | |
| Net Income TTM | $-8M | $-30M | $-25M | $-15M | $-13M | · | |
| P/E | -0.1 | -0.6 | -70.0 | -182.4 | -134.5 | · | |
| Earnings Yield | -1094.8% | -173.5% | -1.4% | -0.55% | -0.74% | · |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $151.7K | $6M | $27.0K | $15.6K | $6.5K | $5.1K | $394.8K | $426.4K | $618.9K | $1M | $1M | $853.1K | $622.8K | $41.9K | $1M | $2M | |
| Cost of Revenue | $229.5K | $11.1K | $21.6K | $12.5K | $5.2K | $4.1K | $315.8K | $341.1K | $438.4K | $512.0K | $1M | $678.3K | $502.4K | $29.4K | $1M | $1M | |
| Gross Profit | $-93.9K | $7M | $5.4K | $3.1K | $1.3K | $1.0K | $79.0K | $85.3K | $180.4K | $614.7K | $252.6K | $174.8K | $120.4K | $12.5K | $268.3K | $361.8K | |
| R&D Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $564.4K | $2M | $2M | $3M | $3M | $2M | |
| Operating Expenses | $3M | $3M | $4M | $3M | $3M | $2M | $3M | $4M | $15M | $8M | $11M | $5M | $5M | $5M | $6M | $4M | |
| Operating Income | $-3M | $3M | $-4M | $-3M | $-3M | $-2M | $-3M | $-4M | $-15M | $-7M | $-11M | $-5M | $-5M | $-5M | $-6M | $-4M | |
| Interest Expense | $100.5K | $109.3K | $233.4K | $127.1K | $228.7K | $255.8K | $265.6K | $229.1K | $159.7K | $0 | $-1.4K | $95.5K | $95.5K | $93.4K | $94.5K | $32.2K | |
| Other Non-op | · | · | $0 | $0 | $0 | · | $0 | $0 | $-1M | · | · | $0 | $0 | · | · | · | |
| Pretax Income | $-5M | $4M | · | · | $-2M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | · | $330.2K | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $3M | $719.2K | $-5M | $-2M | $-2M | $-3M | $-4M | $-15M | $-7M | $-11M | $-5M | $-4M | $-5M | $-5M | $-4M | |
| EPS (Basic) | $-11.58 | $1.39 | $-1.77 | $-2.02 | $-40.72 | $-11.80 | $-10.47 | $-4.13 | $-16.16 | $-0.20 | $-0.30 | $-0.14 | $-0.12 | $-0.14 | $-0.15 | $-0.11 | |
| EPS (Diluted) | $-11.58 | $1.39 | $-1.77 | $-2.02 | $-40.72 | $-11.80 | $-10.47 | $-4.13 | $-16.16 | $-0.20 | $-0.30 | $-0.14 | $-0.12 | $-0.14 | $-0.15 | $-0.11 | |
| Shares (Basic) | 1,327,966 | 904,312 | -46,618,136 | 2,260,068 | 296,686 | 186,149 | -38,144,933 | 945,585 | 945,585 | 37,223,588 | -71,791,923 | 35,926,921 | 35,910,669 | 35,883,779 | -71,605,400 | 35,835,135 | |
| Shares (Diluted) | 1,327,966 | 904,312 | -46,618,136 | 2,260,068 | 296,686 | 186,149 | -38,144,933 | 945,585 | 945,585 | 37,223,588 | -71,791,923 | 35,926,921 | 35,910,669 | 35,883,779 | -71,605,400 | 35,835,135 | |
| EBITDA | $-3M | $3M | · | $-3M | $-3M | $-2M | · | $-4M | $-15M | $-7M | · | $-5M | $-5M | $-5M | · | $-4M |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $741.3K | $1M | $2M | $1M | $2M | $1M | $5M | $998.2K | $1M | $4M | $4M | $11M | $7M | $18M | $22M | $26M | |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | · | $0 | $10M | $10M | $10M | $0 | |
| Receivables | $18.5K | $74.8K | $32.2K | $30.7K | $21.6K | $87.5K | $582.2K | $651.8K | $655.0K | $903.9K | $2M | $710.1K | $707.2K | $252.7K | $417.7K | $355.6K | |
| Prepaid Expense | $282.5K | $297.8K | $222.2K | $210.7K | $295.5K | $256.3K | $328.2K | $356.2K | $404.9K | $783.4K | $1M | $2M | $1M | $1M | $1M | $2M | |
| Other Current Assets | $97.7K | $119.8K | $77.6K | $250.3K | $141.0K | $443.3K | $113.5K | $88.1K | $164.6K | $187.3K | $230.9K | $174.9K | $327.1K | $317.0K | $196.0K | $205.9K | |
| Current Assets | $1M | $2M | $2M | $2M | $3M | $2M | $6M | $2M | $2M | $6M | $6M | $14M | $20M | $30M | $34M | $29M | |
| PP&E (Net) | $21M | $21M | $21M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $20M | $15M | $13M | $12M | $11M | $11M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $27M | · | · | · | $23M | · | · | · | $13M | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Other Non-current Assets | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $56.5K | $137.6K | $211.0K | $253.1K | $333.9K | $419.0K | |
| Total Assets | $27M | $27M | $25M | $25M | $29M | $26M | $30M | $27M | $27M | $30M | $29M | $36M | $39M | $44M | $47M | $51M | |
| Accounts Payable | $11M | $12M | $13M | $19M | $19M | $20M | $22M | $23M | $17M | $10M | $6M | $3M | $2M | $1M | $1M | $1M | |
| Short-term Debt | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $19M | $20M | $21M | $27M | $27M | $27M | $30M | $30M | $23M | $13M | $9M | $5M | $5M | $5M | $3M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.5K | · | $56.7K | |
| Deferred Tax | · | · | $24.9K | · | · | · | $40.9K | · | · | · | $146.9K | · | · | · | $0 | · | |
| Other Non-current Liabilities | · | $692.5K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $19M | $22M | $22M | $28M | $29M | $35M | $37M | $37M | $33M | $22M | $15M | $12M | $11M | $11M | $9M | $9M | |
| Long-term Debt | · | · | $0 | $0 | $367.2K | $8M | $7M | $6M | $10M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Total Debt | $7M | $7M | · | $7M | $6M | $6M | · | $6M | · | · | · | $117.7K | $97.1K | $68.0K | · | · | |
| Common Stock | $161 | $112 | $328 | $262 | $215 | $4.5K | $111 | $3.8K | $3.8K | $3.8K | $3.6K | $3.6K | $3.6K | $3.6K | $3.6K | $3.6K | |
| Paid-in Capital | · | · | $111M | $107M | $105M | $94M | $94M | $87M | $87M | $87M | $84M | $84M | $83M | $83M | $83M | $83M | |
| Retained Earnings | $-110M | $-105M | $-109M | $-109M | $-105M | $-103M | $-101M | $-97M | $-93M | $-78M | $-71M | $-60M | $-55M | $-51M | $-46M | $-40M | |
| Stockholders' Equity | $7M | $6M | $3M | $-2M | $-52.0K | $-9M | $-7M | $-10M | $-6M | $9M | $13M | $24M | $29M | $33M | $37M | $43M | |
| Liabilities + Equity | $27M | $27M | $25M | $25M | $29M | $26M | $30M | $27M | $27M | $30M | $29M | $36M | $39M | $44M | $47M | $51M |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $127.1K | $142.0K | $156.9K | $173.9K | $291.9K | $419.0K | $682.5K | $128.4K | $129.9K | $243.5K | $274.6K | $277.5K | $284.3K | $298.8K | $261.2K | $164.3K | |
| Stock-based Comp | $1.2K | $10.0K | $9.2K | $205.5K | $278.3K | $275.6K | $292.1K | $232.4K | $239.8K | $244.7K | $261.3K | $219.8K | $263.4K | $259.2K | $286.2K | $302.3K | |
| Other Non-cash | · | · | · | · | · | $-2M | · | · | · | $3M | · | · | · | $874.4K | · | · | |
| Operating Cash Flow | $-4M | $-2M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-5M | $-4M | $-4M | $-6M | $-9M | $-4M | $-4M | $-2M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $113.4K | $37.1K | $-18.6K | $129.7K | $4M | $630.0K | $2M | $300.4K | $68.7K | $10M | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | · | $-113.4K | $-37.1K | $18.6K | $-129.7K | $-4M | $9M | $-2M | $-300.4K | $-68.7K | $7M | |
| Stock Issued | · | · | $4M | $0 | $1M | $1.7K | $4M | $0 | $0 | $3M | $14.0K | $84 | $7.7K | $1.9K | $5.8K | $1.7K | |
| Net Stock Activity | · | · | · | · | · | $1.7K | · | · | · | $3M | · | · | · | $1.9K | · | · | |
| Financing Cash Flow | $3M | $851.6K | $4M | $2M | $5M | $-53.1K | $7M | $3M | $2M | $4M | $-15.2K | $-8.9K | $7.7K | $1.9K | $-39.8K | $6M | |
| Net Change in Cash | $-487.6K | $-723.6K | $855.6K | $-1M | $1M | $-4M | $4M | $-163.1K | $-3M | $489.0K | $-8M | $4M | $-11M | $-4M | $-4M | $11M | |
| Free Cash Flow | · | · | · | · | · | $-4M | · | · | · | $-4M | · | · | · | $-4M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 100.5% | · | 20.0% | 20.0% | 20.0% | · | 20.0% | 29.1% | 54.6% | · | 20.5% | 19.3% | 29.9% | · | 20.0% | |
| Operating Margin | · | 49.8% | · | -21095.3% | -52886.7% | -38811.5% | · | -865.4% | -2445.8% | -665.1% | · | -595.2% | -724.2% | -12798.9% | · | -222.2% | |
| Net Margin | · | · | · | -29183.2% | -29431.0% | -43373.6% | · | -915.1% | -2469.1% | -662.8% | · | -578.9% | -691.1% | -12106.8% | · | -216.4% | |
| Pretax Margin | · | 58.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | 52.0% | · | -21095.3% | -52886.7% | -30538.8% | · | -865.4% | -2445.8% | -643.5% | · | -595.2% | -724.2% | -12085.4% | · | -222.2% | |
| ROA | -18.8% | · | · | -17.5% | -6.9% | -7.8% | · | -12.6% | -46.1% | -20.2% | · | -11.4% | -9.9% | -10.7% | · | -7.3% | |
| ROE | -141.5% | · | · | 75.4% | 60.7% | -2460.8% | · | -56.2% | -137.1% | -36.1% | · | -14.9% | -11.5% | -12.4% | · | -8.1% | |
| ROIC | · | 23.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 2.6 | 4.4 | 6.6 | · | 12.5 | |
| Quick Ratio | 0.0 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.4 | · | 2.2 | 4.0 | 6.3 | · | 11.6 | |
| Debt / Equity | 0.9 | 1.1 | · | -3.2 | -123.6 | -0.7 | · | -0.6 | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | -31.5 | 29.6 | · | -25.9 | -15.1 | -7.7 | · | -16.5 | -94.8 | · | · | -53.2 | -47.2 | -57.4 | · | · |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 80.1 | · | 0.0 | 0.0 | 0.0 | · | 0.6 | 0.9 | 1.9 | · | 1.6 | 1.2 | 0.1 | · | 8.5 |
估值 (TTM) 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $7M | · | $453.6K | $1M | $2M | · | $3M | $3M | $3M | · | $3M | $3M | $5M | · | $5M | |
| Net Income TTM | $-8M | $-5M | · | $-13M | $-23M | $-29M | · | $-32M | $-32M | $-22M | · | $-18M | $-17M | $-15M | · | $-14M | |
| P/E | -0.1 | -0.0 | · | -0.3 | -0.1 | -0.5 | · | -1.0 | -1.6 | -116.7 | · | -149.0 | -184.7 | -136.7 | · | -223.4 | |
| Earnings Yield | -1060.7% | -14763.9% | · | -351.1% | -684.2% | -182.1% | · | -95.7% | -64.2% | -0.86% | · | -0.67% | -0.54% | -0.73% | · | -0.45% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $54.2K | $3M | $3M | $7M | $0 |
| 毛利率 % | 20.0% | 37.4% | 19.7% | 38.5% | — |
| 营业利润率 % | -24270.7% | -1148.5% | -905.0% | -224.3% | — |
| 净收入 | $-8M | $-30M | $-25M | $-15M | $-13M |
| 稀释后每股收益 (EPS) | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 2.5 | -0.9 | — | 1.0 | — |
| 流动比率 | 0.1 | 0.2 | — | 11.5 | 17.4 |
| 速动比率 | 0.1 | 0.2 | — | 11.0 | 15.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-13M | $-14M | $-29M | $-21M | $-11M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 1 家申报者 · $2K 总计 · 截至 2025年12月31日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q1 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 5 (0 与上一季度对比) | 4 (+3 与上一季度对比) | 5 (+3 与上一季度对比) | 0 (-2 与上一季度对比) | +22K |
与Q4 2025对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1848 | 1903 | 100.00% | 股份 |
公司内部人士 10 位内幕人士 · 5 位高管 · 5 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Hing C. Wong, Ph.D. | Chief Executive Officer | 2026年7月29日 P | 125845 | 1 | 0 | $59882 |
| Rebecca Byam | Chief Financial Officer | 2025年5月7日 P | 43010 | 0 | 0 | $0 |
| Lee Flowers | SVP of Business Development | 2026年7月29日 P | 8691 | 1 | 0 | $19959 |
| Peter Rhode | Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. | 2023年12月11日 M | 77500 | 0 | 0 | $0 |
| Jin-An Jiao | VP of Development | 2022年5月31日 M | 45141 | 0 | 0 | $0 |
| Scott T Garrett | 董事 | 2026年7月29日 P | 41644 | 1 | 0 | $19959 |
| Gary M Winer | 董事 | 2025年5月16日 P | 4075 | 0 | 0 | $0 |
| Rick S. Greene | 董事 | 2025年5月7日 P | 2066 | 0 | 0 | $0 |
| Lisa M. Giles | 董事 | 2024年6月14日 A | 35815 | 0 | 0 | $0 |
| Medmira Capital Ltd. | 10% 所有者 | 2021年9月15日 J | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Hing C. Wong, Ph.D. ×2 申报 | 2025年6月13日 | 23.38% | 修订 | — | SEC |
| Hing C. Wong (2) | 2024年11月22日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 1 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 2004 SH | 2026年8月8日 | 每日 |